Pharmacokinetic, pharmacodynamic and covariate analysis of subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma. [electronic resource]
Producer: 20130418Description: 823-9 p. digitalISSN:- 1179-1926
- Administration, Intravenous
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Area Under Curve
- Boronic Acids -- administration & dosage
- Bortezomib
- Humans
- Injections, Subcutaneous
- Middle Aged
- Multiple Myeloma -- blood
- Proteasome Endopeptidase Complex -- blood
- Pyrazines -- administration & dosage
- Recurrence
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.